The Biotech Growth Trust (LON:BIOG) Announces Earnings Results

The Biotech Growth Trust (LON:BIOG) announced its earnings results on Wednesday. The company reported GBX (1.90) earnings per share for the quarter, Digital Look Earnings reports. The Biotech Growth Trust had a net margin of 140.73% and a negative return on equity of 8.91%. The firm had revenue of GBX 43 million during the quarter.

The Biotech Growth Trust Trading Down 1.4%

Shares of BIOG opened at GBX 1,246.24 on Friday. The firm has a market cap of £244.28 million, a PE ratio of -87.15 and a beta of 0.60. The Biotech Growth Trust has a 12 month low of GBX 701.63 and a 12 month high of GBX 1,374. The stock has a fifty day moving average price of GBX 1,294.19 and a 200-day moving average price of GBX 1,251.

The Biotech Growth Trust Company Profile

The Biotech Growth Trust seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).